Ryan L. Setten
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- RNA modifications and cancer
- CRISPR and Genetic Engineering
- RNA Research and Splicing
- DNA and Nucleic Acid Chemistry
Papers in
-
- RNA Interference and Gene Delivery 5
- Advanced biosensing and bioanalysis techniques 4
- Genomics and Chromatin Dynamics 3
- Epigenetics and DNA Methylation 1
- FOXO transcription factor regulation 1
-
- MicroRNA in disease regulation 1
- Co-authors
- John J. Rossi (5 shared papers)Si‐ping Han (3 shared papers)Xian-Shu Cui (2 shared papers)Steven F. Dowdy (2 shared papers)Nagy Habib (1 shared paper)Helen L. Lightfoot (1 shared paper)Dustin E. Schones (2 shared papers)Candi Trac (2 shared papers)
- Journals
- Nature Reviews Drug Discovery (3 papers)Current Pharmaceutical Biotechnology (1 paper)Nucleic Acid Therapeutics (1 paper)The AAPS Journal (1 paper)Epigenetics & Chromatin (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Ryan L. Setten
10 papers receiving 1.4k citations
Ryan L. Setten's Hit Papers
Peers
Comparison fields: 5 of 92
- Cancer Research 273
- Molecular Biology 1.1k
- Biomaterials 74
- Immunology 100
- Genetics 104
Countries citing papers authored by Ryan L. Setten
This map shows the geographic impact of Ryan L. Setten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan L. Setten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan L. Setten more than expected).
Fields of papers citing papers by Ryan L. Setten
This network shows the impact of papers produced by Ryan L. Setten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan L. Setten. The network helps show where Ryan L. Setten may publish in the future.
Co-authors
The 22 scholars most cited alongside Ryan L. Setten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The current state and future directions of RNAi-based therapeutics Hit paper breakdown → | 2019 | 1125 |
| 2 | 2022 | 95 | |
| 3 | 2014 | 61 | |
| 4 | 2018 | 39 | |
| 5 | 2014 | 15 | |
| 6 | 2013 | 9 | |
| 7 | 2021 | 8 | |
| 8 | 2019 | 8 | |
| 9 | 2023 | 7 | |
| 10 | 2019 | 7 |
About Ryan L. Setten
Ryan L. Setten is a scholar working on Molecular Biology, Cancer Research, Pathology and Forensic Medicine, Hematology and Genetics, having authored 10 papers that have together received 1.4k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (5 papers), Advanced biosensing and bioanalysis techniques (4 papers), Genomics and Chromatin Dynamics (3 papers), Chronic Myeloid Leukemia Treatments (1 paper), Epigenetics and DNA Methylation (1 paper), MicroRNA in disease regulation (1 paper), Chemotherapy-induced organ toxicity mitigation (1 paper) and FOXO transcription factor regulation (1 paper). The work is most often cited by research in Cancer Research (273 citations), Molecular Biology (1.1k citations), Biomaterials (74 citations), Immunology (100 citations) and Genetics (104 citations). Ryan L. Setten has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include John J. Rossi, Si‐ping Han, Xian-Shu Cui, Steven F. Dowdy, Nagy Habib, Helen L. Lightfoot, Dustin E. Schones, Candi Trac, Juan Du and Kevin D. Brown. Their work appears in journals such as Nature Reviews Drug Discovery, Current Pharmaceutical Biotechnology, Nucleic Acid Therapeutics, The AAPS Journal and Epigenetics & Chromatin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.